Clinical Trial Update: Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx) [Phase 2]

View source ↗

Summary

Phase 2 results for the GemPOx regimen (gemcitabine, paclitaxel, and oxaliplatin) in central nervous system germ cell tumors; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Germ Cell Tumor

Drugs mentioned

• Gemcitabine (Gemzar) (gemcitabine)
• Oxaliplatin (Eloxatin) (oxaliplatin)
• Paclitaxel (Taxol) (paclitaxel)

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: CNS Germ Cell Tumor | Phase 2 | Status: COMPLETED | Results posted: 2025-10-27